Skip to main navigation
logo
Investors
  • News Archive
  • Past Events and Presentations
  • Stock History

News Archive

News Archive

Feb 20, 2003
Mylan Reaches Final Agreement with Bristol-Myers Squibb
Dec 20, 2002
Mylan is Granted Summary Judgment on all Three Strengths of Mirtazapine
Nov 11, 2002
Mylan Laboratories Inc. Announces First ANDA Approval for Isotretinoin; Bertek Pharmaceuticals Inc. to Market Amnesteem
Oct 29, 2002
Mylan Reports Record Second Quarter EPS of $.54
Oct 28, 2002
Mylan Laboratories Inc. Increases Dividend 25%
Oct 16, 2002
Mylan Confirms Potential First-to-File ANDA on Pfizer's Multi-Billion Dollar Drug Norvasc
Oct 15, 2002
Mylan Announces Second Quarter Fiscal 2003 Earnings Release Date and Conference Call
Oct 09, 2002
Mylan Names Patrick J. Gallagher, Vice President, Business Development
Sep 16, 2002
Mylan Declares Regular Quarterly Cash Dividend
Jul 25, 2002
Mylan Reports Record First Quarter Revenue and Earnings

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 120
  • Page 121
  • Page 122
  • Page 123
  • Page 124
  • Page 125
  • Current page 126
  • Page 127
  • Page 128
  • Next page next ›
  • Last page last »
Share

Utility Nav

  • Privacy Statement
  • Terms and Conditions
©2026 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.
mylan